Tobias Miller1, Melissa C Goude1, Todd C McDevitt2, Johnna S Temenoff3. 1. Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, 313 Ferst Drive, Atlanta, GA 30332, USA. 2. Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, 313 Ferst Drive, Atlanta, GA 30332, USA; Parker H. Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, GA 30332, USA. 3. Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, 313 Ferst Drive, Atlanta, GA 30332, USA; Parker H. Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, GA 30332, USA. Electronic address: johnna.temenoff@bme.gatech.edu.
Abstract
Glycosaminoglycans (GAGs) are linear, negatively charged polysaccharides that interact with a variety of positively charged growth factors. In this review article the effects of engineering GAG chemistry for molecular delivery applications in regenerative medicine are presented. Three major areas of focus at the structure-function-property interface are discussed: (1) macromolecular properties of GAGs; (2) effects of chemical modifications on protein binding; (3) degradation mechanisms of GAGs. GAG-protein interactions can be based on: (1) GAG sulfation pattern; (2) GAG carbohydrate conformation; (3) GAG polyelectrolyte behavior. Chemical modifications of GAGs, which are commonly performed to engineer molecular delivery systems, affect protein binding and are highly dependent on the site of modification on the GAG molecules. The rate and mode of degradation can determine the release of molecules as well as the length of GAG fragments to which the cargo is electrostatically coupled and eventually released from the delivery system. Overall, GAG-based polymers are a versatile biomaterial platform offering novel means to engineer molecular delivery systems with a high degree of control in order to better treat a range of degenerated or injured tissues.
Glycosaminoglycans (n class="Chemical">GAGs) are linear, negatively charged polysaccharides that interact with a variety of positively charged growth factors. In this review article the effects of engineering GAG chemistry for molecular delivery applications in regenerative medicine are presented. Three major areas of focus at the structure-function-property interface are discussed: (1) macromolecular properties of GAGs; (2) effects of chemical modifications on protein binding; (3) degradation mechanisms of GAGs. GAG-protein interactions can be based on: (1) GAG sulfation pattern; (2) GAG carbohydrate conformation; (3) GAG polyelectrolyte behavior. Chemical modifications of GAGs, which are commonly performed to engineer molecular delivery systems, affect protein binding and are highly dependent on the site of modification on the GAG molecules. The rate and mode of degradation can determine the release of molecules as well as the length of GAG fragments to which the cargo is electrostatically coupled and eventually released from the delivery system. Overall, GAG-based polymers are a versatile biomaterial platform offering novel means to engineer molecular delivery systems with a high degree of control in order to better treat a range of degenerated or injured tissues.
Authors: Cristal I Gama; Sarah E Tully; Naoki Sotogaku; Peter M Clark; Manish Rawat; Nagarajan Vaidehi; William A Goddard; Akinori Nishi; Linda C Hsieh-Wilson Journal: Nat Chem Biol Date: 2006-07-30 Impact factor: 15.040
Authors: Peter J Roughley; Lee I Melching; Terrence F Heathfield; Richard H Pearce; John S Mort Journal: Eur Spine J Date: 2006-05-31 Impact factor: 3.134
Authors: Torri E Rinker; Brandon D Philbrick; Marian H Hettiaratchi; David M Smalley; Todd C McDevitt; Johnna S Temenoff Journal: Acta Biomater Date: 2017-12-30 Impact factor: 8.947
Authors: Marian H Hettiaratchi; Catherine Chou; Nicholas Servies; Johanna M Smeekens; Albert Cheng; Camden Esancy; Ronghu Wu; Todd C McDevitt; Robert E Guldberg; Laxminarayanan Krishnan Journal: Tissue Eng Part A Date: 2017-03-24 Impact factor: 3.845
Authors: J R Krieger; M E Ogle; J McFaline-Figueroa; C E Segar; J S Temenoff; E A Botchwey Journal: Biomaterials Date: 2015-10-23 Impact factor: 12.479